On July 21, Hansoh Pharmaceutical declined 3.33% in regular trading, trading at HK$31.98/share, with turnover of HK$71.85 million.

Within the Pharmaceuticals sector where Hansoh Pharmaceutical belongs, the overall sector trended lower. Among individual stocks, CSPC Pharma down 2.0%, SBP Group down 2.32%, Hengrui Pharma down 4.0%, Asymchem down 0.08%, Simcere Pharma down 0.46%.

Hansoh Pharmaceutical Group Co., Ltd. is a China-based investment holding company principally engaged in the research and development, manufacturing, and sale of pharmaceutical products. Its innovative drug portfolio covers anti-tumor, anti-infection, central nervous system diseases, metabolic diseases, and other therapeutic areas.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)